2219 York Road, Suite 102, Lutherville-Timonium, MD 21093
(410) 469-7111

FAQ About Corneal Crosslinking (CXL) and Keratoconus

Welcome to our FAQ page, where we delve into some of the most frequently asked questions about keratoconus, shedding light on treatments such as Corneal Cross-Linking (CXL), corneal transplants, Scleral lenses, PROSE, EyePrint Pro, and more. This resource is designed to provide clarity and insight into various aspects of keratoconus treatments, helping you navigate your journey with informed confidence.

Keratoconus Specialists of Maryland, where we have been dedicated to providing expert care for individuals with keratoconus for over 40 years. Our practice is at the forefront of keratoconus treatment, offering a comprehensive range of services tailored to meet the unique needs of each patient.

With a deep understanding of the challenges faced by those with keratoconus, our team is committed to delivering the highest quality of care. We pride ourselves on our ability to restore hope and improve the vision of many patients who had previously felt hopeless about their condition. Our personalized approach ensures that every patient receives the best possible treatment, empowering them to achieve better vision and an enhanced quality of life.

We are proud to serve patients from across Maryland, including the cities of Annapolis, Baltimore, Bethesda, Columbia, Frederick, Glen Burnie, Hunt Valley, Owings Mills, Pikesville, Rockville, and Towson. We also welcome many patients traveling from Virginia, including Alexandria, Fairfax, Reston, Tysons, and Vienna, as well as from Pennsylvania, including Harrisburg, Hershey, Lancaster, and York.

FAQs on Corneal Crosslinking (CXL) and Keratoconus

What is Corneal Cross-Linking (CXL)?

Corneal Cross-Linking (CXL) is a minimally invasive procedure used to strengthen the cornea in patients with keratoconus. The treatment involves applying riboflavin (vitamin B2) eye drops to the cornea and then exposing it to ultraviolet (UV) light. This process increases the collagen cross-linking within the cornea, making it more stable and less likely to continue bulging.

Who is a candidate for CXL?

Candidates for CXL are typically individuals with progressive keratoconus or those with corneal ectasia following refractive surgery. The ideal candidate is someone whose condition is worsening, as evidenced by changes in vision or corneal shape. An eye care professional can determine candidacy through a comprehensive eye exam and corneal imaging.

What are the benefits of CXL?

The primary benefit of CXL is its ability to halt the progression of keratoconus, reducing the likelihood of further vision loss. In some cases, CXL may also lead to a mild flattening of the cornea, which can improve vision and make contact lens fitting easier.

What is the recovery process like after CXL?

Recovery from CXL varies among individuals. Patients may experience mild discomfort, light sensitivity, and blurred vision for the first few days post-procedure. It’s important to follow the post-operative care instructions provided by your eye care professional, including the use of prescribed eye drops and avoiding rubbing the eyes. Vision may fluctuate for several weeks to months as the cornea heals.

Are there any risks associated with CXL?

As with any medical procedure, CXL carries some risks, though they are relatively rare. Potential risks include infection, corneal haze, and temporary or permanent changes in vision. It’s crucial to discuss the risks and benefits of CXL with your eye care professional to make an informed decision.

Does CXL Cross-linking cure keratoconus?

CXL Cross-linking does not cure keratoconus; it stops the progression of the condition. Many people still need treatments like scleral lenses or PVR PROSE after CXL Cross-linking.

Will I need lenses after CXL Cross-linking?

In many cases, lenses are needed after CXL Cross-linking to correct vision.